^
Association details:
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Source:
Title:

Loss of a Negative Feedback Loop between IRF8 and AR Promotes Prostate Cancer Growth and Enzalutamide Resistance

Published date:
04/29/2020
Excerpt:
Decreased expression of IRF8 positively associated with CRPC progression and ENZ resistance.
DOI:
10.1158/0008-5472.CAN-19-2549